Adam Acosta is an associate in the Firm's Global Antitrust and Competition Practice. His practice focuses on antitrust litigation, government investigations, and related counseling. Mr. Acosta represents clients in a wide range of industries and frequently represents clients in the pharmaceutical industry with cases involving allegations of reverse payment settlements and product hopping. Prior to joining White & Case, Mr. Acosta completed a two-year clerkship in the US District Court for the Southern District of Indiana. He currently serves as an elected board member for the Hispanic Bar Association of DC and is active in the American Bar Association's Antitrust Section.
United States: Pharmaceutical Antitrust, Global Competition Review, 2015, (co-author)
Hospital-Merger Litigation in 2014 Leads to Divestitures, Trying Antitrust, ABA Trial Practice Committee, 2015
Predictive Coding: The Beginning of a New E-Discovery Era, 56 RES GESTAE 8, 2012, republished with updates at 30 COMP. & INTERNET LAW. J. 26, 2013
Len Bias' Death Still Haunts Crack-Cocaine Offenders After Twenty Years: Failing to Reduce Disproportionate Crack-Cocaine Sentences Under 18 U.S.C. § 3582, 53 HOW. L.J. 825, 2010